Issue Date: July 21, 2008
Pacific Biosciences Wins Financing
Pacific Biosciences has snagged $100 million in financing from a group of firms that includes the investment arm of semiconductor company Intel. Pacific anticipates the funding will enable it to bring its single-molecule, real-time DNA sequencing platform to market by 2010. It hopes to enable a human genome to be sequenced for $1,000, a feat the firm believes would revolutionize health care.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society